Daiichi Life Group. Inc. TSE:8750
Daiichi Life : Consolidated Financial ResultsPDF file will open in a new window (2025 001)
Source: MarketScreener
(Unofficial Translation)
Consolidated Summary Report under Japanese GAAP for the Fiscal Year Ended March 31, 2026
Company Name: Daiichi Life Group, Inc. Stock exchange listings: Tokyo
May 15, 2026
Code Number: 8750 URL: https://www.daiichilife-group.com/ Representative: Tetsuya Kikuta, President, Representative Director
For inquiry: Shunsuke Murakami, General Manager, Investor Relations Group, Corporate Planning Unit TEL: (03)3216-1222
General meeting of shareholders: June 22, 2026 Dividend payment date: June 23, 2026 Securities report issue date: June 16, 2026
Supplementary information for financial statements: Available
Explanatory meeting to be held: Yes (for institutional investors and analysts)
(Amounts of less than one million yen are truncated.)
-
Consolidated Financial Data for the Fiscal Year Ended March 31, 2026
Consolidated results of operations
(% represents the change from the previous fiscal year)
Ordinary Revenues
Ordinary Profit
Net Income attributable to shareholders of Parent Company
Fiscal Year Ended
Unit: million yen
%
Unit: million yen
%
Unit: million yen
%
March 31, 2026
11,308,275
14.5
753,688
(0.3)
436,597
(4.8)
March 31, 2025
9,876,615
(10.4)
755,728
40.2
458,407
42.9
Note. Comprehensive income (loss) for the fiscal years ended March 31, 2026 and 2025 were 817,590 million yen and (75,635) million yen, respectively.
Net Income per Share
Diluted Net Income per Share
Ratio of Net Income to Shareholders' Equity
Ratio of Ordinary Profits to Total Assets
Ratio of Ordinary Profits to Ordinary Revenues
Fiscal Year Ended
yen
yen
%
%
%
March 31, 2026
119.83
119.82
11.1
1.0
6.7
March 31, 2025
123.72
123.70
12.2
1.1
7.7
(Reference) Income (loss) from investment in affiliates (Equity method) March 31, 2026: 23,055 million yen March 31, 2025: 3,526 million yen Note. The Company conducted a 1:4 share split on April 1, 2025. Net income per share and diluted net income per share are calculated,
assuming that the share split was conducted at the beginning of the previous fiscal year.
Consolidated financial condition
Total Assets
Total Net Assets
Ratio of Net Assets Attributable to the Company's shareholders
to Total Assets
Total Net Assets per Share
As of
Unit: million yen
Unit: million yen
%
yen
March 31, 2026
74,159,096
4,254,212
5.7
1,181.36
March 31, 2025
69,404,123
3,639,369
5.2
988.61
(Reference) Net assets attributable to the Company's shareholders as of March 31, 2026 and 2025 were 4,254,002 million yen and 3,639,112 million yen,respectively.
Note. The Company conducted a 1:4 share split on April 1, 2025. Total net assets per share are calculated, assuming that the share split was conducted at the beginning of the previous fiscal year.
Consolidated cash flows
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Cash and cash equivalents at the end of the year
Fiscal Year Ended
Unit: million yen
Unit: million yen
Unit: million yen
Unit: million yen
March 31, 2026
792,158
(926,255)
(127,230)
2,087,588
March 31, 2025
592,578
(980,460)
(73,570)
2,313,529
-
Dividends on Common Stock
Dividends per share
Total Dividends (Annual)
Dividend payout ratio (Consolidated)
Dividend on net assets ratio (Consolidated)
1st quarter-end
2nd quarter-end
3rd quarter-end
Fiscal year-end
Annual
Fiscal Year Ended
yen
yen
yen
yen
yen
million yen
%
%
March 31, 2025
-
61.00
-
76.00
137.00
126,075
29.5
3.5
March 31, 2026
-
24.00
-
30.50
54.50
197,225
45.5
5.0
March 31, 2027
(Forecast)
-
36.00
-
36.00
72.00
50.5
Note 1. "Total dividends (Annual)" in the above table excludes dividends of 578 million yen for the fiscal year ended March 31, 2025 and dividends of 866 million yen for the fiscal year ended March 31, 2026 to shares held by the Stock Granting Trust (J-ESOP trust).
2. The Company conducted a 1:4 share split on April 1, 2025. The dividend per share for the fiscal year ended March 31, 2025 does not reflect the share split. Contents for the fiscal year ended March 31, 2026 and fiscal year ending March 31, 2027 (forecast) are stated in figures after the share split.
-
Consolidated Earnings Forecasts for the Fiscal Year ending March 31, 2027
(% represents the change from the previous fiscal year)
Ordinary Revenues
Ordinary Profit
Net Income attributable to shareholders of Parent Company
Net Income per Share
Fiscal Year Ending
Unit: million yen
%
Unit: million yen
%
Unit: million yen
%
yen
March 31, 2027
10,666,000
(5.7)
869,000
15.3
513,000
17.5
142.46
Note. The Company conducted a 1:4 share split on April 1, 2025. Net income per share in Forecasts of Consolidated Financial Results for the fiscal year ending March 31, 2027 has taken the impact of the said share split into account.
- Notes
Significant changes in the scope of consolidation during the period :No
Changes in accounting policies, accounting estimates and correction of past errors:Yes
Changes in accounting policies due to revision of accounting standards:Yes
Changes in accounting policies due to reasons other than item (A) above:No
Changes in accounting estimates:No
Correction of past errors:No
(3) Number of shares outstanding (common stock)
As of March 31, 2026
As of March 31, 2025
(A) Total shares outstanding including treasury stock:
3,621,895,219
3,700,398,400
(B) Shares of treasury stock held:
20,944,204
19,361,896
Year ended March 31, 2026
Year ended March 31, 2025
(C) Average outstanding shares:
3,643,385,226
3,705,314,875
Note.
For the number of shares used as the basis for the calculation of consolidated net income per share, please refer to (Per-share information),
(5) Notes to the Consolidated Financial Statements, under [3. Unaudited Consolidated Financial Statements] of the Appendix.
The Company conducted a 1:4 share split on April 1, 2025. The number of shares is calculated assuming that the share split was conducted at the beginning of the previous fiscal year.
The number of treasury stocks includes the shares of the Company (18,079,918 shares as of March 31, 2026 and 16,903,200 shares as of March 31, 2025) held by the Stock Granting Trust (J-ESOP trust).
-
Non-consolidated Financial Data for the Fiscal Year Ended March 31, 2026
Non-consolidated results of operations
(% represents the change from the previous fiscal year)
Sales Revenues
Operating Profit
Fiscal Year Ended
Unit: million yen
%
Unit: million yen
%
March 31, 2026
334,518
48.3
300,264
51.0
March 31, 2025
225,620
15.4
198,865
11.8
Ordinary Profit
Net Income
Fiscal Year Ended
Unit: million yen
%
Unit: million yen
%
March 31, 2026
288,783
51.8
295,300
63.5
March 31, 2025
190,248
10.8
180,629
3.6
Net Income per Share
Diluted Net Income per Share
Fiscal Year Ended
yen
yen
March 31, 2026
81.05
81.04
March 31, 2025
48.75
48.74
Note. The Company conducted a 1:4 share split on April 1, 2025. Net income per share and diluted net income per share are calculated, assuming that the share split was conducted at the beginning of the previous fiscal year.
Non-consolidated financial condition
Total Assets
Total Net Assets
Ratio of Net Assets Attributable to the Company's shareholders
to Total Assets
Total Net Assets per Share
As of
Unit: million yen
Unit: million yen
%
yen
March 31, 2026
2,771,624
1,238,860
44.7
343.98
March 31, 2025
2,508,002
1,197,842
47.8
325.34
(Reference) Net assets attributable to the Company's shareholders as of March 31, 2026 and 2025 were 1,238,650 million yen and 1,197,584 million yen, respectively.
Note. The Company conducted a 1:4 share split on April 1, 2025. Total net assets per share are calculated, assuming that the share split was conducted at the beginning of the previous fiscal year.
*This report is exempt from the audits of CPAs or Audit firms.
*Notes for using earnings forecast in this report and others:
This report contains forward-looking statements, such as earnings forecasts, regarding the intent, beliefs and current expectations of the Company and its management with respect to the expected financial condition and results of operations of the Company. These statements necessarily depend upon information currently available to the Company and its management and on assumptions that the Company and its management believe are appropriate. Forward-looking statements are not guarantees of future performance and actual results may differ materially from any future results expressed or implied by forward-looking statements. Forward-looking statements are subject to various risks and uncertainties, such as fluctuations in market conditions, including changes in the value of equity securities and changes in interest rates and forward exchange rates, the occurrence of illegal acts, operational and system risks, risks associated with general economic conditions in Japan and other factors. Important factors which may affect the Company's financial condition, results of operations and business performance are not limited to the factors described above. In light of the risks and uncertainties relating to forward-looking statements, investors are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this release.
The Company has changed its trade name from Dai-ichi Life Holdings, Inc. to its current name (Daiichi Life Group, Inc.) on the effective date of April 1, 2026.
Table of Contents of AppendixConsolidated Results of Operations 2
Results of Operations and Financial Condition 2
Forecasts 3
Basic Rationale for Selection of Accounting Standards 4
Unaudited Consolidated Financial Statements 5
Consolidated Balance Sheet 5
Consolidated Statement of Earnings and Comprehensive Income 7
Consolidated Statement of Earnings 7
Consolidated Statement of Comprehensive Income 9
Consolidated Statement of Changes in Net Assets 10
Consolidated Statement of Cash Flows 14
Notes to the Consolidated Financial Statements 16
(Notes on Going-Concern Assumptions) 16
(Segment Information and Others) 17
(Per-share Information) 20
(Subsequent Events) 20
The Company plans to hold a conference call for institutional investors and analysts regarding its financial results for the fiscal year ended March 31, 2026 on May 15, 2026. The material for the conference call will be posted on TDnet and the Company's website.
Consolidated Results of Operations
Results of Operations and Financial Condition
Results of Operations for the Fiscal Year Ended March 31, 2026
Ordinary revenues of Dai-ichi Life Holdings, Inc. (hereinafter the "Company" or the "Parent Company") and its consolidated subsidiaries (collectively, the "Group") for the fiscal year ended March 31, 2026 increased by 1,431.6 billion yen, or 14.5%, to 11,308.2 billion yen, consisting of (1) 6,944.0 billion yen (2.1% increase) of premium and other income, (2) 3,735.3 billion yen (47.7% increase) of investment income, and (3) 628.8 billion yen (14.6% increase) of other ordinary revenues, compared to the prior fiscal year. Premium and other income increased due mainly to the increase in sales at The Dai-ichi Frontier Life Insurance Co., Ltd.
Meanwhile, the Group's ordinary expenses for the fiscal year ended March 31, 2026 increased by 15.7%, to 10,554.5 billion yen, consisting of (1) 6,447.1 billion yen (2.0% decrease) of benefits and claims, (2) 1,814.9 billion yen (430.8% increase) of provision for policy reserves and others, (3) 867.0 billion yen (3.0% increase) of investment expenses, (4) 1,048.2 billion yen (6.1% increase) of operating expenses, and (5) 377.2 billion yen (2.7% increase) of other ordinary expenses, compared to the prior fiscal year.
Consequently, the Group's ordinary profit for the fiscal year ended March 31, 2026, compared to the prior fiscal year, decreased by 2.0 billion yen or 0.3%, to 753.6 billion yen. Its net income attributable to shareholders of parent company for the fiscal year, which is ordinary profit after extraordinary gains and losses, provision for reserve for policyholder dividends, and total of corporate income taxes, decreased by 4.8%, to 436.5 billion yen.
Net income attributable to shareholders of parent company for the fiscal year decreased compared to the prior fiscal year. The decrease was due mainly to the application of the new U.S. insurance accounting standard by Protective Life Corporation.
Dai-ichi Life Holdings, Inc. changed its trade name to Daiichi Life Group, Inc. on April 1, 2026.
The Dai-ichi Frontier Life Insurance Co., Ltd. changed its trade name to Daiichi Frontier Life Insurance Co., Ltd. on April 1, 2026.
Financial Condition as of March 31, 2026
Condition of assets, liabilities, and net assets
The Group's total assets as of March 31, 2026, compared to March 31, 2025, increased by 6.9%, to 74,159.0 billion yen, mainly consisting of 55,576.2 billion yen (4.8% increase) of securities, 4,997.1 billion yen (2.6% decrease) of loans, 1,239.2 billion yen (2.7% decrease) of tangible fixed assets, and 2,062.9 billion yen (0.7% increase) of reinsurance receivable.
The Group's total liabilities as of March 31, 2026 increased by 6.3% to 69,904.8 billion yen, mainly consisting of 61,255.1 billion yen (3.4% increase) of policy reserves and others, compared to March 31, 2025.
The Group's total net assets as of March 31, 2026 increased by 16.9% to 4,254.2 billion yen. Net unrealized gains on securities, net of tax, as of March 31, 2026, which are included in the Group's total net assets, increased by 43.1% to 1,372.6 billion yen.
Cash flows
Cash Flows from Operating Activities
The Company's net cash flows provided in operating activities for the fiscal year ended March 31, 2026 increased by 199.5 billion yen to 792.1 billion yen, compared to the prior fiscal year.
Cash Flows from Investing Activities
The Company's net cash flows used by investing activities for the fiscal year ended March 31, 2026 decreased by
54.2 billion yen to 926.2 billion yen, compared to the prior fiscal year.
Cash Flows from Financing Activities
The Company's net cash flows used by financing activities for the fiscal year ended March 31, 2026 increased by
53.6 billion yen to 127.2 billion yen, compared to the prior fiscal year.
Cash and Cash Equivalents at the End of the Year
As a result, the Company's cash and cash equivalents as of March 31, 2026 decreased by 225.9 billion yen to 2,087.5 billion yen from 2,313.5 billion yen at the end of the prior fiscal year.
Forecasts
The Company forecasts its consolidated ordinary revenues to decrease compared to the previous fiscal year to 10,666.0 billion yen, mainly due to the decrease in investment income at Protective Life Corporation. The Company also forecasts ordinary profit and net income attributable to shareholders of parent company to increase to 869.0 billion yen and 513.0 billion yen, respectively, mainly due to the increase in the overseas life insurance businesses.
The above forecasts are based on the Company's current expectations, taking into account factors such as the information currently available and past experience, and assuming that interest rates, forward exchange rates and stock prices do not substantially vary from those as of March 31, 2026. Therefore, actual results may substantially differ from the forecasts.
Basic Rationale for Selection of Accounting Standards
The Group is evaluating International Financial Reporting Standards (IFRS), assuming that the Group will adopt IFRS in the future.
Regarding the accounting standards for insurance contracts (IFRS 17), taking into account the potential effect on the method of creating financial statements, we are continuously examining their progress.
Unaudited Consolidated Financial Statements
(1) Consolidated Balance Sheet
ASSETS
As of
March 31, 2025
(Unit: million yen) As of
March 31, 2026
Cash and deposits
1,889,228
1,974,671
Call loans
566,500
591,000
Monetary claims bought
207,197
186,044
Money held in trust
899,485
1,384,128
Securities
53,033,910
55,576,274
Loans
5,130,891
4,997,117
Tangible fixed assets
1,273,200
1,239,280
Land
881,367
836,165
Buildings
342,470
362,617
Leased assets
8,432
6,919
Construction in progress
8,496
1,011
Other tangible fixed assets
32,432
32,566
Intangible fixed assets
1,044,116
963,435
Software
143,253
139,206
Goodwill
328,427
302,276
Leased assets
3
1
Other intangible fixed assets
572,431
521,950
Reinsurance receivable
2,048,027
2,062,981
Other assets
3,195,461
5,075,928
Deferred tax assets
125,713
125,244
Customers' liabilities for acceptances and guarantees
11,192
4
Reserve for possible loan losses
(20,374)
(16,563)
Reserve for possible investment losses
(427)
(450)
Total assets
69,404,123
74,159,096
(Unit: million yen)
As of
March 31, 2025
As of
March 31, 2026
LIABILITIES
Policy reserves and others
59,246,559
61,255,107
Reserves for outstanding claims
1,426,541
1,624,508
Policy reserves
57,387,967
59,192,742
Reserve for policyholder dividends
432,050
437,856
Reinsurance payable
301,779
1,514,606
Short-term bonds payable
41,874
7,822
Bonds payable
1,153,124
1,337,337
Other liabilities
4,340,668
5,109,011
Payables under repurchase agreements
1,699,129
1,831,637
Other liabilities
2,641,538
3,277,374
Net defined benefit liabilities
157,929
19,352
Reserve for retirement benefits of directors, executive officers and 613 556
corporate auditors
Reserve for possible reimbursement of prescribed claims
1,300
1,600
Reserves under the special laws
342,194
357,500
Reserve for price fluctuations
342,194
357,500
Deferred tax liabilities
97,710
233,435
Deferred tax liabilities for land revaluation
69,806
68,547
Acceptances and guarantees
11,192
4
Total liabilities
65,764,753
69,904,883
NET ASSETS
Capital stock
344,353
344,702
Capital surplus
330,686
331,035
Retained earnings
1,376,222
1,611,421
Treasury stock
(9,938)
(16,949)
Total shareholders' equity
2,041,323
2,270,210
Net unrealized gains (losses) on securities, net of tax
959,318
1,372,692
Deferred hedge gains (losses)
(124,157)
(205,617)
Reserve for land revaluation
48,984
54,143
Foreign currency translation adjustments
378,906
387,289
Accumulated remeasurements of defined benefit plans
126,449
199,082
Net unrealized gains (losses) on total policy reserves and other reserves of foreign subsidiaries, net of tax
208,286
176,203
Total accumulated other comprehensive income
1,597,788
1,983,792
Subscription rights to shares
257
210
Total net assets
3,639,369
4,254,212
Total liabilities and net assets
69,404,123
74,159,096
(2) Consolidated Statement of Earnings and Comprehensive Income
[Consolidated Statement of Earnings]
(Unit: million yen)
Year ended
March 31, 2025
Year ended
March 31, 2026
ORDINARY REVENUES
9,876,615
11,308,275
Premium and other income
6,799,366
6,944,066
Investment income
2,528,416
3,735,313
Interest and dividends
1,585,938
1,670,711
Gains on money held in trust
-
78,727
Gains on investments in trading securities
331,097
680,562
Gains on sale of securities
570,776
780,465
Gains on redemption of securities
23,236
26,323
Foreign exchange gains
-
364,124
Reversal of reserve for possible loan losses
4,778
3,728
Other investment income
12,588
4,875
Gains on investments in separate accounts
-
125,795
Other ordinary revenues
548,833
628,895
ORDINARY EXPENSES
9,120,887
10,554,587
Benefits and claims
6,581,327
6,447,114
Claims
1,998,461
1,808,520
Annuities
1,063,768
1,037,349
Benefits
728,415
777,298
Surrender values
1,637,819
1,289,905
Other refunds
1,152,863
1,534,039
Provision for policy reserves and others
341,899
1,814,937
Provision for policy reserves
333,462
1,806,266
Provision for interest on policyholder dividends
8,437
8,670
Investment expenses
842,153
867,008
Interest expenses
49,312
62,247
Losses on money held in trust
1,284
-
Losses on sale of securities
457,799
574,123
Losses on valuation of securities
22,313
7,993
Losses on redemption of securities
10,502
29,422
Derivative transaction losses
77,703
95,101
Foreign exchange losses
126,738
-
Provision for reserve for possible investment losses
292
24
Write-down of loans
6,562
3,065
Depreciation of real estate for rent and others
14,257
14,826
Other investment expenses
71,716
80,202
Losses on investments in separate accounts
3,668
-
Operating expenses
988,092
1,048,234
Other ordinary expenses
367,414
377,293
Ordinary profit
755,728
753,688
(Unit: million yen)
Year ended
Year ended
March 31, 2025
March 31, 2026
EXTRAORDINARY GAINS
19,020
22,507
Gains on disposal of fixed assets
18,881
13,570
Gains on change in equity
-
8,748
Other extraordinary gains
139
188
EXTRAORDINARY LOSSES
75,793
42,546
Losses on disposal of fixed assets
25,927
17,110
Impairment losses on fixed assets
2,243
10,058
Provision for reserve for price fluctuations
17,802
15,305
Second career special support expenses
28,883
-
Other extraordinary losses
936
71
Provision for reserve for policyholder dividends
100,000
107,500
Income before income taxes
598,955
626,149
Corporate income taxes-current
124,754
181,547
Corporate income taxes-deferred
15,793
8,003
Total of corporate income taxes
140,548
189,551
Net income
458,407
436,597
Net income attributable to shareholders of parent company
458,407
436,597
[Consolidated Statement of Comprehensive Income]
(Unit: million yen)
Year ended
March 31, 2025
Year ended
March 31, 2026
Net income
458,407
436,597
Other comprehensive income
Net unrealized gains (losses) on securities, net of tax
(716,189)
427,660
Deferred hedge gains (losses)
(24,636)
(76,414)
Reserve for land revaluation
(2,249)
40
Foreign currency translation adjustments
128,323
10,917
Remeasurements of defined benefit plans, net of tax
9,030
72,539
Net unrealized gains (losses) on total policy reserves and other reserves of foreign subsidiaries, net of tax
61,673 (31,631)
Share of other comprehensive income of subsidiaries and affiliates
accounted for under the equity method
10,005
(22,118)
Total other comprehensive income
(534,042)
380,992
Comprehensive income
(75,635)
817,590
(Details)
Attributable to shareholders of parent company
(75,635)
817,590
(3) Consolidated Statement of Changes in Net Assets
Year ended March 31, 2025
(Unit: million yen)
Shareholders'equity
Accumulated other comprehensive income
Capital stock
Capital surplus
Retained earnings
Treasury stock
Total shareholders' equity
Net unrealized gains (losses) on securities, net of tax
Deferred hedge gains (losses)
Balance at the beginning of
the year
344,205
330,538
1,214,608
(17,258)
1,872,093
1,733,897
(101,756)
Cumulative effect of changes in accounting
policies
(2,100)
(2,100)
(63,010)
Balance at the beginning of the year after reflecting the effect of changes in
accounting policies
344,205
330,538
1,212,507
(17,258)
1,869,992
1,670,886
(101,756)
Changes for the year
Issuance of new shares
148
148
296
Dividends
(162,939)
(162,939)
Net income attributable to shareholders of parent
company
458,407
458,407
Purchase of treasury
stock
(101,849)
(101,849)
Disposal of treasury
stock
(152)
278
125
Cancellation of treasury
stock
(108,890)
108,890
-
Change in scope of
equity method
-
Transfer from retained earnings to capital
surplus
109,043
(109,043)
-
Transfer from reserve for land revaluation
(23,010)
(23,010)
Others
300
300
Net changes of items other than shareholders'
equity
(711,568)
(22,400)
Total changes for the year
148
148
163,714
7,319
171,330
(711,568)
(22,400)
Balance at the end of the
year
344,353
330,686
1,376,222
(9,938)
2,041,323
959,318
(124,157)
(Unit: million yen)
Accumulated other comprehensive income
Subscription rights to shares
Total net assets
Reserve for land revaluation
Foreign currency translation adjustments
Accumulated remeasurements of defined benefit plans
Net unrealized gains (losses) on total policy reserves and other reserves of foreign subsidiaries, net of tax
Total accumulated other comprehensive income
Balance at the beginning of
the year
28,223
247,433
117,420
(15,457)
2,009,761
302
3,882,157
Cumulative effect of changes in accounting
policies
162,070
99,060
96,959
Balance at the beginning of the year after reflecting the effect of changes in
accounting policies
28,223
247,433
117,420
146,613
2,108,821
302
3,979,117
Changes for the year
Issuance of new shares
296
Dividends
(162,939)
Net income attributable to shareholders of parent
company
458,407
Purchase of treasury
stock
(101,849)
Disposal of treasury
stock
125
Cancellation of treasury
stock
-
Change in scope of
equity method
-
Transfer from retained earnings to capital
surplus
-
Transfer from reserve for land
revaluation
(23,010)
Others
300
Net changes of items other than shareholders'
equity
20,760
131,472
9,029
61,673
(511,032)
(45)
(511,077)
Total changes for the year
20,760
131,472
9,029
61,673
(511,032)
(45)
(339,747)
Balance at the end of the
year
48,984
378,906
126,449
208,286
1,597,788
257
3,639,369
Year ended March 31, 2026
(Unit: million yen)
Shareholders'equity
Accumulated other comprehensive income
Capital stock
Capital surplus
Retained earnings
Treasury stock
Total shareholders' equity
Net unrealized gains (losses) on securities, net of tax
Deferred hedge gains (losses)
Balance at the beginning of
the year
344,353
330,686
1,376,222
(9,938)
2,041,323
959,318
(124,157)
Cumulative effect of changes in accounting
policies
-
Balance at the beginning of the year after reflecting the effect of changes in
accounting policies
344,353
330,686
1,376,222
(9,938)
2,041,323
959,318
(124,157)
Changes for the year
Issuance of new shares
349
349
698
Dividends
(157,336)
(157,336)
Net income attributable to shareholders of parent
company
436,597
436,597
Purchase of treasury
stock
(107,597)
(107,597)
Disposal of treasury
stock
(77)
1,860
1,783
Cancellation of treasury
stock
(98,725)
98,725
-
Change in scope of
equity method
59,723
59,723
Transfer from retained earnings to capital
surplus
98,802
(98,802)
-
Transfer from reserve for land
revaluation
(5,010)
(5,010)
Others
28
28
Net changes of items other than shareholders'
equity
413,373
(81,460)
Total changes for the year
349
349
235,199
(7,011)
228,886
413,373
(81,460)
Balance at the end of the
year
344,702
331,035
1,611,421
(16,949)
2,270,210
1,372,692
(205,617)
(Unit: million yen)
Accumulated other comprehensive income
Subscription rights to shares
Total net assets
Reserve for land revaluation
Foreign currency translation adjustments
Accumulated remeasurements of defined benefit plans
Net unrealized gains (losses) on total policy reserves and other reserves of foreign subsidiaries, net of tax
Total accumulated other comprehensive income
Balance at the beginning of
the year
48,984
378,906
126,449
208,286
1,597,788
257
3,639,369
Cumulative effect of changes in accounting
policies
-
-
Balance at the beginning of the year after reflecting the effect of changes in
accounting policies
48,984
378,906
126,449
208,286
1,597,788
257
3,639,369
Changes for the year
Issuance of new shares
698
Dividends
(157,336)
Net income attributable to shareholders of parent
company
436,597
Purchase of treasury
stock
(107,597)
Disposal of treasury
stock
1,783
Cancellation of treasury
stock
-
Change in scope of
equity method
59,723
Transfer from retained earnings to capital
surplus
-
Transfer from reserve for land
revaluation
(5,010)
Others
28
Net changes of items other than shareholders'
equity
5,158
8,382
72,632
(32,082)
386,003
(47)
385,956
Total changes for the year
5,158
8,382
72,632
(32,082)
386,003
(47)
614,843
Balance at the end of the
year
54,143
387,289
199,082
176,203
1,983,792
210
4,254,212
(4) Consolidated Statement of Cash Flows
(Unit: million yen)
Year ended
Year ended
March 31, 2025
March 31, 2026
CASH FLOWS FROM OPERATING ACTIVITIES
Income before income taxes
598,955
626,149
Depreciation of real estate for rent and others
14,257
14,826
Depreciation
101,534
98,095
Impairment losses on fixed assets
2,243
10,058
Amortization of goodwill
25,230
32,665
Increase (decrease) in reserves for outstanding claims
(9,310)
33,049
Increase (decrease) in policy reserves
372,955
1,958,999
Provision for interest on policyholder dividends
8,437
8,670
Provision for (reversal of) reserve for policyholder dividends
100,000
107,500
Increase (decrease) in reserve for possible loan losses
(4,715)
(3,632)
Increase (decrease) in reserve for possible investment losses
(21)
23
Write-down of loans
6,562
3,065
Increase (decrease) in net defined benefit liabilities
(41,678)
(37,179)
Increase (decrease) in reserve for retirement benefits of directors, executive officers and corporate
(60)
(56)
auditors
Increase (decrease) in reserve for possible reimbursement of prescribed claims
300
300
Increase (decrease) in reserve for price fluctuations
17,802
15,305
Interest and dividends
(1,585,938)
(1,670,711)
Securities related losses (gains)
(430,826)
(1,001,607)
Interest expenses
49,312
62,247
Foreign exchange losses (gains)
126,738
(364,124)
Losses (gains) on disposal of fixed assets
1,100
1,652
Equity in losses (income) of affiliates
(3,526)
(23,055)
Losses (gains) on sale of stocks of subsidiaries and affiliated companies
-
(145)
Decrease (increase) in reinsurance receivable
5,253
(32,360)
Decrease (increase) in other assets unrelated to investing and financing activities
(111,816)
(1,687,768)
Increase (decrease) in reinsurance payable
(192,710)
1,202,401
Increase (decrease) in other liabilities unrelated to investing and financing activities
(186,955)
119,068
Others, net
218,212
(123,738)
Subtotal
(918,663)
(650,298)
Interest and dividends received
1,812,356
2,016,842
Interest paid
(49,724)
(58,230)
Policyholder dividends paid
(99,028)
(110,364)
Others, net
(50,563)
(274,135)
Corporate income taxes (paid) refund
(101,796)
(131,654)
Net cash flows provided by (used in) operating activities
592,578
792,158
(Unit: million yen)
Year ended March 31, 2025
Year ended March 31, 2026
CASH FLOWS FROM INVESTING ACTIVITIES
Net decrease (increase) in cash and deposits
(19,328)
(116,348)
Purchases of monetary claims bought
(20,465)
(24,731)
Proceeds from sale and redemption of monetary claims bought
33,458
35,647
Purchases of money held in trust
(263,790)
(464,952)
Proceeds from decrease in money held in trust
251,365
58,516
Purchases of securities
(13,549,721)
(18,529,564)
Proceeds from sale and redemption of securities
12,807,996
17,814,152
Origination of loans
(1,265,718)
(1,018,068)
Proceeds from collection of loans
1,050,850
1,162,295
Net increase (decrease) in short-term investing
286,211
217,780
Others, net
-
132
Total of net cash provided by (used in) investment transactions
(689,142)
(865,141)
Total of net cash provided by (used in) operating activities and investment transactions
(96,563)
(72,983)
Acquisition of tangible fixed assets
(60,115)
(77,168)
Proceeds from sale of tangible fixed assets
47,011
57,424
Acquisition of intangible fixed assets
(44,347)
(42,618)
Proceeds from sale of intangible fixed assets
-
24
Acquisitions of stock of subsidiaries resulting in change in scope of consolidation
(233,785)
-
Proceeds from acquisitions of stock of subsidiaries resulting in change in scope of consolidation
-
1,245
Payments for execution of assets retirement obligations
(81)
-
Acquisitions of stock of subsidiaries
-
(21)
Net cash flows provided by (used in) investing activities
(980,460)
(926,255)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from borrowings
-
218,500
Repayment of borrowings
(1,720)
(213,385)
Proceeds from issuing bonds
316,230
185,921
Redemption of bonds
(111,718)
-
Repayment of financial lease obligations
(11,141)
(2,548)
Net increase (decrease) in short-term financing
(813)
(51,140)
Purchase of treasury stock
(101,849)
(107,597)
Cash dividends paid
(162,356)
(156,780)
Acquisitions of stock of subsidiaries that do not result in change in scope of consolidation
(200)
(199)
Others, net
0
0
Net cash flows provided by (used in) financing activities
(73,570)
(127,230)
Effect of exchange rate changes on cash and cash equivalents
2,610
35,387
Net increase (decrease) in cash and cash equivalents
(458,841)
(225,940)
Cash and cash equivalents at the beginning of the year
2,772,370
2,313,529
Cash and cash equivalents at the end of the year
2,313,529
2,087,588
(5) Notes to the Consolidated Financial Statements (Notes on Going-Concern Assumptions)
None
(Changes in Accounting Policies)
Effective the fiscal year ended March 31, 2026, certain consolidated overseas subsidiaries have applied the accounting standard (ASC) "Financial Services - Insurance" (Topic 944) (ASU No. 2018-12 issued on August 15, 2018, ASU No. 2019-09 issued on November 15, 2019, ASU No. 2020-11 issued on November 5, 2020 and ASU No. 2022-05 issued on December 15, 2022) issued by the Financial Accounting Standards Board (FASB).
Through this application, the accounting treatment of the liability for future policy benefits, the measurement of benefits with market risks at fair value, and the amortization methods of deferred acquisition costs of insurance contracts have been updated.
This change in accounting policy has been applied retrospectively, and the consolidated financial statements for the previous fiscal year have been retroactively restated.
As a result, income before income taxes for the previous fiscal year increased by ¥36,655 million compared to that before the retrospective application. In addition, policy reserves and others for the previous fiscal year decreased by ¥319,646 million and other assets for the previous fiscal year decreased by ¥80,428 million. Furthermore, as a result of the cumulative impact reflected in net assets at the beginning balance of the previous fiscal year, the beginning balance of retained earnings decreased by ¥2,100 million, and the beginning balance of accumulated other comprehensive income increased by ¥99,060 million.
(Segment Information and Others) [Segment Information]
Overview of reportable segments
The reportable segments of the Company are components of the Company about which separate financial information is available. The segments are subject to periodic review to enable the Company's Board of Directors to decide on allocation of business resources and evaluate business performance.
The Company is a holding company which manages life insurance companies in Japan and elsewhere as well as other subsidiaries and affiliated companies. These companies are subject to regulations of the Insurance Business Act.
The Company's operations are therefore segmented based on the operations of its subsidiaries and affiliated companies and the Company's three reportable segments are the Domestic Insurance Business, the Overseas Insurance Business, and Other Business.
The Domestic Insurance Business consists of subsidiaries that engage in the insurance business in Japan. The Overseas Insurance Business consists of subsidiaries and affiliated companies that engage in the insurance business overseas. The Company, subsidiaries and affiliated companies that do not operate either the Domestic Insurance Business or the Overseas Insurance Business are segmented as Other Business and mainly consist of business administration of the group companies and non-insurance businesses (asset management business and new fields of business).
Method of calculating ordinary revenues, income or loss, assets and liabilities and others by reportable segment Figures for reportable segment income are based on ordinary profit.
Intersegment revenue is based on market prices.
Information on ordinary revenues, income or loss, assets and liabilities, and others by reportable segment For the fiscal year ended March 31, 2026
(Unit: million yen)
Reportable segment
Adjustments (Note 2)
Amount on consolidated financial statements (Note 3)
Domestic Insurance Business
Overseas Insurance Business
Other Business
Total
Ordinary revenues (Note 1)
8,155,625
3,523,786
79,050
11,758,462
(450,187)
11,308,275
Intersegment transfers
514,005
35,578
392,427
942,011
(942,011)
-
Total
8,669,631
3,559,364
471,478
12,700,474
(1,392,198)
11,308,275
Segment income (loss)
676,269
112,629
340,204
1,129,103
(375,415)
753,688
Segment assets
45,559,593
28,033,406
4,478,272
78,071,272
(3,912,175)
74,159,096
Segment liabilities
42,438,108
26,847,438
1,601,056
70,886,603
(981,720)
69,904,883
Other relevant information
Depreciation of real estate for rent and others
14,817
9
-
14,826
-
14,826
Depreciation
55,002
37,797
5,295
98,095
-
98,095
Amortization of goodwill
1,037
11,568
20,059
32,665
-
32,665
Interest and dividends
1,026,992
646,435
387,122
2,060,549
(389,838)
1,670,711
Interest expenses
26,488
28,567
20,192
75,248
(13,000)
62,247
Equity in income (loss) of affiliates
-
11,144
11,911
23,055
-
23,055
Extraordinary gains
13,701
48
8,893
22,643
(136)
22,507
Extraordinary losses
33,126
9,452
69
42,649
(102)
42,546
[Impairment losses]
[1,764]
[8,243]
[50]
[10,058]
[-]
[10,058]
Taxes
156,208
28,868
4,484
189,561
(9)
189,551
Investments in affiliated companies
-
154,315
226,967
381,282
-
381,282
Increase in tangible fixed assets and intangible fixed assets
162,365
4,098
1,534
167,998
-
167,998
Note: 1. Ordinary revenues, instead of sales, are presented here.
Adjusted amounts were as follows.
Adjustment for ordinary revenues of ¥(450,187) million was mainly related to ordinary revenues including other ordinary revenues of ¥432,924 million and ordinary expenses including other ordinary expenses of ¥12,968 million reconciled to provision for policy reserves and other ordinary revenues in the Consolidated Statement of Earnings.
Adjustment for segment income (loss) of ¥(375,415) million was mainly related to elimination of dividend income from subsidiaries and affiliated companies.
Adjustment for segment assets of ¥(3,912,175) million was mainly related to elimination of stocks of subsidiaries and affiliated companies.
Adjustment for segment liabilities of ¥(981,720) million was mainly related to elimination of intersegment receivables and payables.
Adjustment for others was mainly related to elimination of intersegment transactions.
Segment income (loss) is reconciled with ordinary profit booked in the Consolidated Statement of Earnings.
[Other Related Information]
For the fiscal year ended March 31, 2026
Product (Service) Segment Information
(Unit: million yen)
Domestic Insurance Business
Overseas Insurance Business
Other Business
Total
Premium and other income
5,108,737
1,835,328
-
6,944,066
Geographic Segment Information
Ordinary Revenues
(Unit: million yen)
Japan
United States of America
Other Areas
Total
7,501,192
2,111,276
1,695,807
11,308,275
Note: 1. Ordinary revenues, instead of sales, are presented here.
2. Based on the location of customers, ordinary revenues are classified by country or region.
Tangible fixed assets
The geographic segment information has been omitted as more than 90% of the Group's tangible fixed assets derive from its business unit in Japan.
Major Customer Information
The major customer information has been omitted as no single customer accounts for 10% or more of the Group's ordinary revenues.
[Impairment Losses on Fixed Assets by Reportable Segment] For the fiscal year ended March 31, 2026
The information on impairment losses on fixed assets by reportable segment has been omitted as it is explained in [Segment Information].
[Amortization of Goodwill and Unamortized Amount of Goodwill by Reportable Segment]
For the fiscal year ended March 31, 2026
(Unit: million yen)
Domestic Insurance Business | Overseas Insurance Business | Other Business | Total | |
Amortization of goodwill | 1,037 | 11,568 | 20,059 | 32,665 |
Unamortized amount of goodwill | 12,193 | 124,593 | 165,488 | 302,276 |
[Gain on Negative Goodwill by Reportable Segment] For the fiscal year ended March 31, 2026
Not applicable
(Per-share Information)
Net assets per share as of March 31, 2026: ¥ 1,181.36
Net income per share for the year ended March 31, 2026: ¥ 119.83
Diluted net income per share for the year ended March 31, 2026: ¥ 119.82 Note.
The Company conducted a 1:4 share split on April 1, 2025. Net assets per share, net income per share and diluted net income per share are calculated assuming that the share split was conducted at the beginning of the current fiscal year.
Reconciliation of net income per share and diluted net income per share was as follows:
Year ended March 31, 2026 (Unit: million yen)
Net income per share
Net income attributable to shareholders of parent company …………………… ¥ 436,597 Net income attributable to other than shareholders of common stock ………… -Net income attributable to shareholders of parent company of common stock … ¥ 436,597 Average number of common stock outstanding: 3,643,385 thousand shares
Diluted net income per share
Adjustments to net income attributable to shareholders of parent company
-
Increase in the number of common stock: 456 thousand shares
(Increase in the number of common stock attributable to subscription
rights
to
shares: 456
thousand shares)
Outline of the dilutive shares which are not counted in the basis of calculation of diluted net income per share because they do not have dilutive effect: Not applicable
Reconciliation of net assets per share was as follows:
As of March 31, 2026 (Unit: million yen) Net assets ……………………………………… ¥ 4,254,212 Adjustments …………………………………… ¥ 210 Subscription rights to shares ……………… ¥ 210
Net assets attributable to common stock ……… ¥ 4,254,002 Number of common stock outstanding: 3,600,951 thousand shares
For the calculation of net income per share, the shares held by "the Stock Granting Trust (J-ESOP)" were included in treasury stock excluded from the average number of common stock outstanding. The average number of the shares held by the J-ESOP during the year ended March 31, 2026 was 14,135 thousand shares. For the calculation of net assets per share, the shares held by the J-ESOP were included in treasury stock excluded from the number of common stock outstanding. The number of the shares held by the J-ESOP as of March 31, 2026 was 18,079 thousand shares.
(Subsequent Events)
Protective Life Corporation, a consolidated subsidiary of the Company, made Portfolio Holding, Inc. a subsidiary of the Company on January 1, 2026 (U.S. time) as it satisfied all customary closing conditions precedent to becoming a subsidiary.
Overview of the business combination
Name and business of the acquired company Company name: Portfolio Holding, Inc.
Business: Non-life insurance business
Purpose of the business combination
Portfolio Holding, Inc. was founded in 1990 and is a leading provider of reinsurance management services and finance and insurance products throughout the U.S. Portfolio Holding, Inc. features a fee-based business model centered around dealer-participating reinsurance programs, offering a stable revenue base and a sales network that is highly complementary to Protective Life Corporation's Asset Protection Division product offerings. Through this acquisition, the Company expects to accelerate the growth of Protective Life Corporation's Asset Protection Division by increasing the proportion of fee-based income, while also expanding Protective Life Corporation's business scale, enhancing profitability, and strengthening its customer base.
Date of business combination January 1, 2026
Ratio of voting rights acquired 100%
Main reason for determining the controlling company
Protective Life Corporation was determined to be the controlling company as it owns 100% of voting rights in Portfolio Holding, Inc..
Acquisition costs
Consideration for the acquisition Cash Approx. USD1.0 billion Acquisition costs Approx. USD1.0 billion
* Consideration for the acquisition may change based on an agreement.
Impact on the consolidated financial results
The acquisition has no impact on the consolidated results of the current fiscal year. The impact on the consolidated results for subsequent fiscal years is currently under review.
Protective Life Corporation, a consolidated subsidiary of the Company, has decided and entered into an agreement to acquire Obsidian Insurance Holdings, Inc. that operates the non-life insurance business in the U.S. on April 28, 2026 (U.S. time).
Purpose of the acquisition
Founded in 2020, Obsidian Insurance Holdings, Inc. operates as a hybrid fronting carrier, supporting property and casualty insurance programs that serve specialized risks, many of which are generally not served by the commercial insurance market. Through the provision of specialized insurance programs and disciplined underwriting management, Obsidian Insurance Holdings, Inc. has established a focused and well-managed platform since its founding. This acquisition will add a complementary line of business to Protective Life Corporation's product suite, and it is expected to contribute to business diversification and earnings stabilization.
Overview of the acquired company
Company name: Obsidian Insurance Holdings, Inc.
Business: Non-life insurance business
Fee revenue, etc. (FY2025 results): USD1.0 billion
Acquisition price
The acquisition price is undisclosed due to an agreement between the parties.
The acquisition price is determined based on a comprehensive consideration of valuations by a third-party
valuation agent and other factors.
Completion of acquisition
This acquisition is subject to regulatory approvals and other conditions and is expected to be completed in the fourth quarter of fiscal year 2026 or the first quarter of fiscal year March 2027.
It has no impact on the consolidated financial results of the current fiscal year. The impact on the consolidated results for subsequent fiscal years is currently under review.